Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)
Clinical trial NCT01336621 · COMPLETED
Trial details
- NCT number
- NCT01336621
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-21
- Primary completion
- 2016-12-14
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.